the 5th Xiamen Forum on Molecular Imaging (MS 2023) and the Symposium on Innovative Radiopharmaceutical Development and Clinical Translation were grandly held.

2024-01-19 10:59:47

On October 20-2, the 5th Xiamen Forum on Molecular Imaging (MS 2023) and the Symposium on Innovative Radiopharmaceutical Development and Clinical Translation were grandly held. As an influential and leading event in the field of molecular imaging, more than 500 industry elites, including experts, doctors and scholars in the field of nuclear medicine, and entrepreneurs, gathered together to deliver keynote speeches and participate in professional sessions to discuss the development direction of the field of molecular imaging.

Dongcheng Pharmaceutical Holding Subsidiary Yanhe Lannacheng Biotechnology Co., Ltd. (hereinafter referred to as Lannacheng") attended the meeting with Professor Chen Xiaoyuan, the chief scientific officer of Kazakhstan, Wu Xiaoming, the general manager of Lannacheng, and Professor Zhang Jingjing, the chief medical officer of Lannacheng, and Professor Zhang Jingjing of Xinjiaxiang National University. At the Symposium on Innovative Radiopharmaceutical Development and Clinical Translation, Lan Nacheng was recognized by industry peers for its cutting-edge technology and innovative research results in the field of nuclear diagnosis and treatment.